Thursday, 21 Nov 2019

RA/Inflammatory arthritis

Datesort ascending Type Title Save
07 Aug 2019 News Periodontal Disease and P. gingivalis Increased in CCP+ Pre-Clinical RA
06 Aug 2019 News War on RA - Part 3: Useless Drugs
06 Aug 2019 Social Metanalysis of 9 studies shows that use of IVIG in ANCA-Associated vasculitis is assoc. w/ significant and rapid improvement in BVAS (SMD –1.7), ANCA (SMD –0.72) and CRP (SMD –0.92) within 2-24 weeks. https://t.co/aw3VjBWCcf
05 Aug 2019 Social War on RA - Parts 1 & 2 - Listen to the podcasts on iTunes or SoundCloud here: Part 1 - Walk on the Moon https://t.co/IZ1cjiwbnZ and Part 2 - All about You https://t.co/u5j8TAZvYC
05 Aug 2019 Social Claims analysis of 88,463 #RA pts (2006-2015) finds no greater risk of cardiovascular events w/ Tocilizumab (11.8/1000 PY) compared to TNF inhibitors (15/1000PY) or abatacept; suggesting no net increase in CVD w/ occ hyperlipidemia seen w/ TCZ https://t.co/6L8aKlLGta
05 Aug 2019 Social Oral candidiasis (OC) is a significant predictor of severe infections during immunosuppressive Rx in ANCA-associated vasculitis. 71 pt cohort study; Predictors of severe infx: low albumin, pulse methylprednisolone (adj HR = 5.44), & OC (adjHR  5.31) https://t.co/BSZzWxDU4k
04 Aug 2019 Social 2nd Edition of my "The War on RA" - being fought daily by rheumatologists - Change, Innovation and Discovery will be driven by Rheumatologists. Rheums must lead the fight to win the immense challenge of #RA today. We need you! https://t.co/7vOzRvvuVi
02 Aug 2019 Social MMP-7 levels studied in myositis pts w/ anti-synthetase syndr (ARS) and fourd to be higher in ARS Ab+ & MDA5 Ab+ PM/DM-ILD patients, and were associated with a worse prognosis. MMP-7 levels associated w/ worse survival (OR 18.0). https://t.co/lGlc5S00sR
02 Aug 2019 Social IL-18 may be a biomarker for Systemic JIA (Stills), higher w/ active dz and hx of MAS. Study of 40 sJIA pts finds elevated IL-18 levels inactive and active dz & with history of MAS. IL-18 was correlated w/ ferritin (R=0.74), CXCL9 (R=0.56), S100 (R=0.47) https://t.co/c0KjAyiEjq
01 Aug 2019 Social RA patients with an inadequate response to adalimumab, in the presence of sufficient/high ADA drug levels, benefit 33% less from switching to another TNF inhibitor, etanercept. Data 449 RA patients in the Reade Rheumatology Registry https://t.co/uBzF8D9KpA
31 Jul 2019 News Top Rheumatology Centers Led by Johns Hopkins
30 Jul 2019 Social The War on RA - is being fought daily by rheumatologists - Change, Innovation and Discovery will be driven by Rheumatologists if we are to win this war. This is the 2nd of a series on the immense challenge of #RA today. We need you! https://t.co/7vOzRvvuVi
30 Jul 2019 News War on RA - Part 2: It's All About You
29 Jul 2019 Social FDA will review to Genentechs application for Rituxan use in pediatric (age >2yrs) granulomatosis with polyangiitis & microscopic polyangiitis. If approved, this would be the 1st pediatric indication for RTX; data based on ths phase IIa PePRS study https://t.co/rRFiyQNKca
28 Jul 2019 Social Im starting a War on RA. I need you go get mad and do your part. Read 1st of 4 part series https://t.co/sR5Z3lq8CU or watch it here https://t.co/s7CVW2dNUT
26 Jul 2019 Social RT @drpnash: Effect of Filgotinib in Rheumatoid Arthritis Refractory to Disease-Modifying Antirheumatic Drugs - JAMA July 23/30 - Filgo (Ja…
25 Jul 2019 News Efficacy of Maintaining or Switching to Baricitinib Monotherapy
24 Jul 2019 Social Im starting a War on RA. I need you go get mad. Read it here https://t.co/sR5Z3lq8CU or watch it here https://t.co/s7CVW2dNUT
23 Jul 2019 Social EUSTAR Study had 1451 systemic sclerosis (SSc) pts enrolled & 706 had complete data. Predictors of #SSc worsening included age, active digital ulcers, lung fibrosis, muscle weakness and elevated C-reactive protein level. https://t.co/QepC6I0HLm
23 Jul 2019 News War on RA - Part 1: Walk on the Moon